These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Effects of acetazolamide on myotonia. Griggs RC; Moxley RT; Riggs JE; Engel WK Ann Neurol; 1978 Jun; 3(6):531-7. PubMed ID: 677818 [TBL] [Abstract][Full Text] [Related]
5. The myotonic disorders and the periodic paralyses. Griggs RC Adv Neurol; 1977; 17():143-59. PubMed ID: 888733 [No Abstract] [Full Text] [Related]
6. The Association of methylprednisolone dosing to cessation of myotonia in a patient with myotonic dystrophy type 1. Horáková M; Horák T; Bednařík J; Voháňka S Neuromuscul Disord; 2020 May; 30(5):427-430. PubMed ID: 32312586 [TBL] [Abstract][Full Text] [Related]
7. Phenytoin and membrane fluidity in myotonic dystrophy. Roses AD; Butterfield A; Appel SH; Chestnut DB Arch Neurol; 1975 Aug; 32(8):535-8. PubMed ID: 168843 [TBL] [Abstract][Full Text] [Related]
8. Dehydroepiandrosterone sulfate (DHEAS) therapy for myotonic dystrophy type 1 and myotonia. Sugino M Intern Med; 2005 Dec; 44(12):1213-4. PubMed ID: 16415539 [No Abstract] [Full Text] [Related]
9. Cardiac conduction in myotonic dystrophy. Griggs RC; Davis RJ; Anderson DC; Dove JT Am J Med; 1975 Jul; 59(1):37-42. PubMed ID: 1138549 [TBL] [Abstract][Full Text] [Related]
10. Possible role of apamin-sensitive K+ channels in myotonic dystrophy. Behrens MI; Jalil P; Serani A; Vergara F; Alvarez O Muscle Nerve; 1994 Nov; 17(11):1264-70. PubMed ID: 7935548 [TBL] [Abstract][Full Text] [Related]
11. Nifedipine in the treatment of myotonia in myotonic dystrophy. Grant R; Sutton DL; Behan PO; Ballantyne JP J Neurol Neurosurg Psychiatry; 1987 Feb; 50(2):199-206. PubMed ID: 3553433 [TBL] [Abstract][Full Text] [Related]
12. Respiratory compromise after MgSO4 therapy for preterm labor in a woman with myotonic dystrophy: a case report. Catanzarite V; Gambling D; Bird LM; Honold J; Perkins E J Reprod Med; 2008 Mar; 53(3):220-2. PubMed ID: 18441730 [TBL] [Abstract][Full Text] [Related]
13. [Treatment of patients with different forms of myotonia with diphenin and novocainamide]. Biriukov VB Zh Nevropatol Psikhiatr Im S S Korsakova; 1976 Sep; 76(9):1333-5. PubMed ID: 1015138 [TBL] [Abstract][Full Text] [Related]
14. Carbamazepine versus diphenylhydantoin in the treatment of myotonia. Sechi GP; Traccis S; Durelli L; Monaco F; Mutani R Eur Neurol; 1983; 22(2):113-8. PubMed ID: 6341070 [TBL] [Abstract][Full Text] [Related]
15. Selenium therapy of myotonic dystrophy. Orndahl G; Rindby A; Selin E Acta Med Scand; 1983; 213(3):237-9. PubMed ID: 6846068 [TBL] [Abstract][Full Text] [Related]
16. Myotonia, potassium and taurine. A preliminary report. Durelli L; Mutani R J Neurol Sci; 1979 Jun; 42(1):103-9. PubMed ID: 448391 [TBL] [Abstract][Full Text] [Related]
17. A comparative study of disopyramide and procainamide in the treatment of myotonia in myotonic dystrophy. Finlay M J Neurol Neurosurg Psychiatry; 1982 May; 45(5):461-3. PubMed ID: 7045292 [TBL] [Abstract][Full Text] [Related]
18. A pilot study of dehydroepiandrosterone sulfate in myotonic dystrophy. Sugino M; Ohsawa N; Ito T; Ishida S; Yamasaki H; Kimura F; Shinoda K Neurology; 1998 Aug; 51(2):586-9. PubMed ID: 9710041 [TBL] [Abstract][Full Text] [Related]